Meeder Advisory Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$442K Sell
2,268
-311
-12% -$64.5K 0.02% 457
2026
Q1
$579K Buy
2,579
+244
+10% +$60.8K 0.02% 368
2025
Q4
$562K Buy
2,335
+389
+20% +$99.5K 0.02% 377
2025
Q3
$533K Buy
1,946
+142
+8% +$38.8K 0.02% 381
2025
Q2
$465K Buy
1,804
+120
+7% +$28.6K 0.02% 393
2025
Q1
$377K Sell
1,684
-193
-10% -$45.1K 0.02% 413
2024
Q4
$429K Sell
1,877
-138
-7% -$33.2K 0.03% 380
2024
Q3
$492K Sell
2,015
-126
-6% -$28.2K 0.03% 343
2024
Q2
$410K Buy
2,141
+1,091
+104% +$221K 0.03% 353
2024
Q1
$208K Buy
+1,050
New +$192K 0.02% 425
2023
Q3
– Sell
-1,507
Closed -$329K – 434
2023
Q2
$329K Sell
1,507
-14
-0.9% -$3.12K 0.04% 346
2023
Q1
$333K Sell
1,521
-190
-11% -$41.2K 0.04% 346
2022
Q4
$356K Buy
+1,711
New +$376K 0.05% 317

Other funds holding RMD

Meeder Advisory Services's RMD Position: Q2 2026 in Review

Meeder Advisory Services reduced its ResMed (RMD) stake by 12% in Q2 2026, selling an estimated $64.5K and leaving 2,268 shares worth $442K. The position accounts for 0.02% of the portfolio, ranked #457.

Meeder Advisory Services first reported a position in RMD in Q4 2022 and has held it in 13 quarters since. The position peaked at $579K in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Meeder Advisory Services held 2,268 shares of ResMed worth $442K as of Q2 2026.
  • Meeder Advisory Services sold 311 ResMed shares in Q2 2026, an estimated $64.5K.
  • ResMed made up 0.02% of Meeder Advisory Services's portfolio in Q2 2026, its #457 holding.
  • Meeder Advisory Services first reported a position in ResMed in Q4 2022 and has held it in 13 quarters since.
  • Meeder Advisory Services's ResMed position peaked at $579K in Q1 2026.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.